HOLLAND OUREN: Open Payments
NPI 1467917468 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 28 payments from 14 companies in 2025. Trend: 2023 $218 · 2024 $376 · 2025 $511
Food & beverage: $431Education: $80
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $123 |
| Gilead Sciences, Inc. | 1 | $80 |
| Merck Sharp & Dohme LLC | 4 | $74 |
| Iovance Biotherapeutics, Inc. | 5 | $67 |
| UROGEN PHARMA, INC. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Genmab U.S., Inc. | 1 | $17 |
| Aveo Pharmaceuticals, Inc. | 1 | $16 |
Products named: Trodelvy, KEYTRUDA, Amtagvi, KISQALI, SCEMBLIX, JELMYTO, Onivyde, VENCLEXTA.
Industry payments across AR — which companies pay providers there.
